Disclosure(s): Cerus: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing); octtapharma: Advisory Board (Ongoing)
Disclosure(s):
Rosemary Kozar, MD, PhD: Cerus: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing); octtapharma: Advisory Board (Ongoing)
Review how endothelial activation and dysfunction originates and propagates to cause and sustain shock, as well potential directed treatments.